Recreational drug toxicity with severe hyperthermia: Rapid onsite treatment and clinical course.
Hyperthermia
Illicit drug
N-Methyl-3,4-methylenedioxyamphetamine
Serotonin syndrome
Sympathomimetics
Toxicology
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
13
06
2022
revised:
05
08
2022
accepted:
22
08
2022
pubmed:
3
9
2022
medline:
30
11
2022
entrez:
2
9
2022
Statut:
ppublish
Résumé
Electronic dance music festivals have gained notoriety in the critical care and emergency medicine fields due to an alarming incidence of hospitalizations and deaths related to the high prevalence of recreational drug use. Recreational drug use toxicity, in part related to sympathomimetic toxidromes, may cause hyponatremia, seizures, rhabdomyolysis, hyperkalemia, acidosis, coagulopathy, circulatory shock, multi-organ failure, and even death. This wide-ranging syndrome has been referred to as psychostimulant drug-induced toxicity. Rapid onsite diagnosis and treatment, with attention to the A-B-C's of clinical emergencies, is essential to preserve life. We describe a patient presenting with the highest recorded core temperature in a survivor of psychostimulant drug-induced toxicity, and emphasize management principles of this life-threatening and increasingly prevalent condition.
Identifiants
pubmed: 36055870
pii: S0735-6757(22)00548-4
doi: 10.1016/j.ajem.2022.08.046
pii:
doi:
Substances chimiques
Illicit Drugs
0
N-Methyl-3,4-methylenedioxyamphetamine
KE1SEN21RM
Central Nervous System Stimulants
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
144.e5-144.e8Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We have no conflicts of interest to disclose.